| Name | 4-(4-phenyl-1,3-thiazol-2-yl)morpholine |
|---|---|
| Synonyms |
2-morpholino-5-phenylthiazole
2-Morpholinyl-4-phenylthiazol 2-Morpholino-4-phenylthiazol 2-morpholino-4-phenyl-thiazole 4-Phenyl-2-morpholinyl-thiazol |
| Description | VPC-14228 is a potent androgen receptor DNA binding domain (AR-DBD) inhibitor that interferes with the interaction of AR with androgen response elements and effectively blocks AR transcriptional activity. VPC-14228 can be used in prostate cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C13H14N2OS |
|---|---|
| Molecular Weight | 246.32800 |
| Exact Mass | 246.08300 |
| PSA | 53.60000 |
| LogP | 2.71170 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H319 |
| Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
|
~68%
19983-28-9 |
| Literature: Keil, D.; Hartmann, H. Liebigs Annalen, 1995 , # 6 p. 979 - 984 |
|
~%
19983-28-9 |
| Literature: Teller, J.; Dehne, H.; Zimmermann, T.; Fischer, G. W.; Olk, B. Journal fuer Praktische Chemie (Leipzig), 1990 , vol. 332, # 4 p. 453 - 460 |
|
~%
19983-28-9 |
| Literature: Ohtsuka; Toyofuku; Miyasaka; Arakawa Chemical and Pharmaceutical Bulletin, 1975 , vol. 23, # 12 p. 3234 - 3242 |
|
~%
19983-28-9 |
| Literature: Perova, N. M.; Egorova, L. G.; Sidorova, L. P.; Novikova, A. P.; Chupakhin, O. N. Chemistry of Heterocyclic Compounds (New York, NY, United States), 1993 , vol. 29, # 4 p. 487 Khimiya Geterotsiklicheskikh Soedinenii, 1993 , # 4 p. 565 - 566 |
| Precursor 6 | |
|---|---|
| DownStream 0 | |